These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25574215)

  • 1. Histological observation of goblet cells following topical rebamipide treatment of the human ocular surface: A case report.
    Kase S; Shinohara T; Kase M
    Exp Ther Med; 2015 Feb; 9(2):456-458. PubMed ID: 25574215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of topical rebamipide on goblet cells in the lid wiper of human conjunctiva.
    Kase S; Shinohara T; Kase M; Ishida S
    Exp Ther Med; 2017 Jun; 13(6):3516-3522. PubMed ID: 28587435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of persistent corneal erosion after administration of topical rebamipide.
    Kashima T; Akiyama H; Miura F; Kishi S
    Clin Ophthalmol; 2012; 6():1403-6. PubMed ID: 22969286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Shamloo K; Barbarino A; Alfuraih S; Sharma A
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4511-4519. PubMed ID: 31675422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical rebamipide improves lid wiper epitheliopathy.
    Itakura H; Kashima T; Itakura M; Akiyama H; Kishi S
    Clin Ophthalmol; 2013; 7():2137-41. PubMed ID: 24204116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Mucins on the Ocular Surface.
    Hori Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES151-DES156. PubMed ID: 30481820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.
    Kashima T; Itakura H; Akiyama H; Kishi S
    Clin Ophthalmol; 2014; 8():1003-10. PubMed ID: 24940041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial.
    Kato K; Miyake K; Kondo N; Asano S; Takeda J; Takahashi A; Takashima Y; Kondo M
    Am J Ophthalmol; 2017 Sep; 181():26-36. PubMed ID: 28669778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy.
    Kato K; Takashima Y; Matsunaga K; Sugimoto M; Matsubara H; Hirano K; Kondo M
    Sci Rep; 2016 Jan; 6():19516. PubMed ID: 26762482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    Hori Y; Kageyama T; Sakamoto A; Shiba T; Nakamura M; Maeno T
    J Ocul Pharmacol Ther; 2017; 33(6):493-497. PubMed ID: 28346860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes.
    Hayashi Y; Toshida H; Matsuzaki Y; Matsui A; Ohta T
    Int Med Case Rep J; 2016; 9():113-6. PubMed ID: 27257394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells.
    Takeji Y; Urashima H; Aoki A; Shinohara H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):259-63. PubMed ID: 22335446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice.
    Jang H; Park S; Lee J; Myung JK; Jang WS; Lee SJ; Myung H; Lee C; Kim H; Lee SS; Jin YW; Shim S
    J Gastroenterol Hepatol; 2018 Apr; 33(4):878-886. PubMed ID: 29047150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caruncle dysgeneses - A case series.
    Wiedenmann CJ; Reinhard T; Auw-Hädrich C
    Am J Ophthalmol Case Rep; 2023 Sep; 31():101868. PubMed ID: 37342568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacrimal Caruncle Nevus with Papilloma.
    Ishikawa E; Sabundayo MS; Takahashi Y; Kakizaki H
    Case Rep Ophthalmol; 2017; 8(3):535-538. PubMed ID: 29422855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells.
    Ueta M; Sotozono C; Yokoi N; Kinoshita S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):688-93. PubMed ID: 23662915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmented Nevus of the Caruncle and Plica Semilunaris: A Case Report.
    Meyerov J; Levitz L; Haddad A
    Case Rep Ophthalmol; 2023; 14(1):83-86. PubMed ID: 36843646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model.
    Urashima H; Okamoto T; Takeji Y; Shinohara H; Fujisawa S
    Cornea; 2004 Aug; 23(6):613-9. PubMed ID: 15257002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.